Remedica expands voluntary drug recall with two additional Clonotril batches

Coverage spans the spectrum: 50% left, 25% center, 25% right. Cross-spectrum coverage is a positive signal — the core facts are broadly accepted. Compare how each side headlines it to understand the editorial framing.